Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIDALA vs Metformin in Type 2 Diabetes
NCT05760456Phase 3Unknown
- Start
- Mar 2023
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of hydromorphone in type 2 diabetes mellitus (T2DM). Status: unknown.
02
Drugs
hydromorphone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT05760456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05760456.